In 2021, the authors performed a pilot study using the serum of 15 EC patients and 15 [non-cancer patients (109)] and identified 16 proteins with diagnostic potential (Supplementary Table S7), four of which (ITIH4, CLU, SERPIN1, and C1R) were validated by western blotting. Here, C1R is linked to cancer.